B Saedi1, M Sadeghi, P Seilani. 1. Otolaryngology Department, Tehran University of Medical Sciences, Tehran, Iran. saedi@tums.ac.ir
Abstract
OBJECTIVE: Mucormycosis is an aggressive fungal infection which may still cause fatal complications. However, the rarity of this disease has made optimal treatment a controversial issue. This study aimed to evaluate the use of topical amphotericin B in endoscopic management of rhinocerebral mucormycosis. SUBJECTS AND METHODS: Thirty patients with infection limited to the nose and sinuses were selected. Patients underwent endoscopic debridement of all necrotic tissue; cottonoid pledgets soaked in amphotericin B solution were then placed in the nasal cavity. Subsequently, long-term antifungal therapy was administered. RESULTS: The overall survival rate was 60 per cent (18 cases); survival rates in the diabetic and malignancy groups were 70.58 and 40 per cent, respectively. Apart from predisposing factors, orbital and maxillary sinus involvement also had a significant correlation with patient outcome. CONCLUSION: Topical use of amphotericin B combined with endoscopic surgical debridement, followed by intravenous amphotericin B treatment, may constitute acceptable management for selected patients, with less morbidity than conventional treatments.
OBJECTIVE:Mucormycosis is an aggressive fungal infection which may still cause fatal complications. However, the rarity of this disease has made optimal treatment a controversial issue. This study aimed to evaluate the use of topical amphotericin B in endoscopic management of rhinocerebral mucormycosis. SUBJECTS AND METHODS: Thirty patients with infection limited to the nose and sinuses were selected. Patients underwent endoscopic debridement of all necrotic tissue; cottonoid pledgets soaked in amphotericin B solution were then placed in the nasal cavity. Subsequently, long-term antifungal therapy was administered. RESULTS: The overall survival rate was 60 per cent (18 cases); survival rates in the diabetic and malignancy groups were 70.58 and 40 per cent, respectively. Apart from predisposing factors, orbital and maxillary sinus involvement also had a significant correlation with patient outcome. CONCLUSION: Topical use of amphotericin B combined with endoscopic surgical debridement, followed by intravenous amphotericin B treatment, may constitute acceptable management for selected patients, with less morbidity than conventional treatments.
Authors: Desderius Celestine Chussi; Michael Kayuza; Marco Magwizi; Peter Shija; Adnan Sadiq; Patrick Amsi; Denis Katundu; Philbert Mtenga Journal: SAGE Open Med Case Rep Date: 2022-02-21
Authors: Megan R D'Andrea; Corey M Gill; Melissa Umphlett; Satish Govindaraj; Anthony Del Signore; Joshua B Bederson; Alfred M C Iloreta; Raj K Shrivastava Journal: J Neurol Surg B Skull Base Date: 2020-02-11
Authors: Ryan Beaver; Brianna Garza; Hasanthi Vallabhaneni; Lizbeth Cahuayme-Zuniga; John Midturi; Tiffany LaDow Journal: Med Mycol Case Rep Date: 2021-07-05